4,215 Cigna Group $CI Shares Bought by Danske Bank A S

Danske Bank A S boosted its stake in shares of Cigna Group (NYSE:CI – Free Report) by 3.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 140,194 shares of the health services provider’s stock after purchasing an additional 4,215 shares during the period. Danske Bank A S’s holdings in Cigna Group were worth $38,109,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. BlackRock Inc. raised its holdings in shares of Cigna Group by 3.7% in the second quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock worth $6,461,457,000 after buying an additional 840,098 shares during the last quarter. GQG Partners LLC acquired a new stake in shares of Cigna Group during the second quarter worth $1,628,918,000. Bank of America Corp DE lifted its stake in shares of Cigna Group by 8.8% during the first quarter. Bank of America Corp DE now owns 3,182,083 shares of the health services provider’s stock worth $848,821,000 after buying an additional 256,677 shares during the period. Dimensional Fund Advisors LP grew its holdings in shares of Cigna Group by 10.8% during the first quarter. Dimensional Fund Advisors LP now owns 2,426,218 shares of the health services provider’s stock valued at $647,008,000 after buying an additional 236,340 shares during the last quarter. Finally, Legal & General Group Plc purchased a new stake in shares of Cigna Group during the second quarter valued at $542,779,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Analyst Ratings Changes

Several research firms recently issued reports on CI. Raymond James Financial downgraded Cigna Group from a “strong-buy” rating to an “outperform” rating and cut their target price for the company from $350.00 to $320.00 in a research report on Monday, August 3rd. Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a research note on Sunday, November 8th. Evercore initiated coverage on Cigna Group in a research report on Wednesday, September 9th. They set an “in-line” rating and a $290.00 price target for the company. Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a research note on Thursday, August 27th. Finally, Sanford C. Bernstein boosted their price target on Cigna Group from $387.00 to $390.00 and gave the company an “outperform” rating in a research note on Wednesday. Fourteen research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to MarketBeat.com, Cigna Group has a consensus rating of “Moderate Buy” and a consensus price target of $336.90.

Check Out Our Latest Stock Report on Cigna Group

Insider Buying and Selling at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 2,677 shares of Cigna Group stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total transaction of $748,515.97. Following the completion of the transaction, the insider owned 25,880 shares in the company, valued at approximately $7,236,306.80. This trade represents a 9.37% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the business’s stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the transaction, the insider directly owned 5,053 shares of the company’s stock, valued at approximately $1,435,304.65. This trade represents a 10.88% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by corporate insiders.

Trending Headlines about Cigna Group

These are some of the CI headlines that stood out recently:

Cigna Group Stock Performance

CI opened at $296.79 on Monday. Cigna Group has a 12-month low of $257.85 and a 12-month high of $318.05. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.66. The firm has a market capitalization of $78.20 billion, a PE ratio of 13.10, a P/E/G ratio of 1.11 and a beta of 0.25. The firm has a 50 day moving average of $287.53 and a two-hundred day moving average of $282.70.

Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings data on Thursday, November 5th. The health services provider reported $7.98 EPS for the quarter, beating the consensus estimate of $7.52 by $0.46. The business had revenue of $73.79 billion during the quarter, compared to analysts’ expectations of $72.64 billion. Cigna Group had a net margin of 2.09% and a return on equity of 19.57%. The business’s quarterly revenue was up 5.6% compared to the same quarter last year. During the same period in the previous year, the business posted $7.83 EPS. On average, analysts anticipate that Cigna Group will post 30.71 EPS for the current year.

Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Thursday, December 3rd will be given a dividend of $1.56 per share. The ex-dividend date is Thursday, December 3rd. This represents a $6.24 dividend on an annualized basis and a yield of 2.1%. Cigna Group’s payout ratio is currently 27.54%.

Cigna Group Profile

(Free Report)

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.

Further Reading

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.